艾洛德尔姆与科尔蒂瓦:对乳腺重建的临床和经济结果的多中心聚合分析
Yousef Tanas1, Peyton Harris2, Grace Gasper3
1From the Department of Surgery, Institute for Reconstructive Surgery, Houston Methodist Hospital, Weill Cornell Medicine, Houston, TX.
Plastic and reconstructive surgery. Global open
|February 19, 2026
概括
这项研究没有发现AlloDerm和Cortiva用于乳房重建的显著临床差异. 然而,由于成本较低,Cortiva的人类细胞皮肤基质提供了更经济的选择.
科学领域:
- 整形外科 整形外科 整形外科
- 再生医学是一种再生医学.
- 卫生经济学 卫生经济学
背景情况:
- 像AlloDerm和Cortiva这样的人类无细胞皮肤矩阵 (hADM) 在假乳重建中使用.
- 这些hADM的比较性临床性能数据有限.
- 这项研究系统地比较了AlloDerm和Cortiva.
研究的目的:
- 为了比较AlloDerm与Cortiva的短期临床结果.
- 为了评估患者报告的身体健康 (BREAST-Q分数).
- 评估外科手术期间的资源使用和成本.
主要方法:
- 在PubMed,Scopus和Web of Science的系统文献搜索.
- 包括AlloDerm和Cortiva的比较研究.
- 随机效应对临床结果和成本数据总结的元分析.
主要成果:
- 包括五项研究 (1180次重建) 在内.
- 在并发症率或BREAST-Q得分方面没有统计学意义上的差异.
- 科尔蒂瓦的收购成本降低了10%至22%,这意味着总成本降低了44%至56%.
结论:
- 在AlloDerm和Cortiva之间没有明确的临床结果差异.
- 科尔蒂瓦展示了显著的成本优势.
- 在等待长期数据的前提下,Cortiva是人工乳房重建的更经济的选择.
更多相关视频
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
4.4K
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
7.2K
相关概念视频
Comparing the Survival Analysis of Two or More Groups
636
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
636
Cancer Survival Analysis
788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788
